Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of Malignant Non-Testicular Germ Cell Tumors in Children
NCT00002489Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Oct 1991
- Primary completion
- Jun 2002
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide, carboplatin, etoposide in extragonadal germ cell tumor (EGGCT), ovarian cancer, sponsored by Memorial Sloan Kettering Cancer Center. Started Oct 1991; status: completed.
02
Drugs
cyclophosphamidecarboplatinetoposide
03
Conditions
extragonadal germ cell tumor (EGGCT)ovarian cancer
Beyond the preview
Go deeper on NCT00002489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002489.